What do systematic reviews say?

Transrectal thermotherapy (add‐on) vs medical treatment

The review found no eligible studies for this question.

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transrectal thermotherapy (add‐on) vs medical treatment

The review found no eligible studies for this question.

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transrectal thermotherapy (add‐on) vs medical treatment

The review found no eligible studies for this question.

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transrectal thermotherapy (add‐on) vs medical treatment

The review found no eligible studies for this question.

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupuncture vs medical treatment

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 78 participants
  Moderate

Acupuncture vs medical treatment

Acupuncture may leads to higher prostatitis symptoms: response defined as a 6‐point decrease in… compared with medical treatment (low certainty).

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  RR 3.57 [1.45, 8.8]
  1 study · 24 participants
  Low

Acupuncture vs medical treatment

• Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 78 participants
  Low

Amiodarone vs placebo or no treatment

Amiodarone may leads to lower sudden cardiac death compared with placebo or no treatment (low certainty).

• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death 2015 · Cochrane Headline outcomes only
  RR 0.76 [0.66, 0.88]
  17 studies · 8383 participants
  Low

Amiodarone vs placebo or no treatment

Amiodarone showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).

• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death 2015 · Cochrane Headline outcomes only
  RR 0.88 [0.78, 1]
  17 studies · 8383 participants
  Low

Amiodarone vs placebo or no treatment

It is very uncertain whether amiodarone changes sudden cardiac death compared with placebo or no treatment (very low certainty).

• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death 2015 · Cochrane Headline outcomes only
  RR 4.32 [0.87, 21.49]
  2 studies · 440 participants
  Very low

Amiodarone vs placebo or no treatment

It is very uncertain whether amiodarone changes all‐cause mortality compared with placebo or no treatment (very low certainty).

• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death 2015 · Cochrane Headline outcomes only
  RR 3.05 [1.33, 7.01]
  2 studies · 440 participants
  Very low

Omeprazole vs placebo

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 30 participants
  Very low

Esomeprazole vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Esomeprazole vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Esomeprazole vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 127 participants
  Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 127 participants
  Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 127 participants
  Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

The review found no eligible studies for this question.

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pantoprazole in higher doses (1.2 mg/kg) vs pantoprazole at lower doses (0.3 mg/kg)

• Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low